2024-04-012025-03-312025-03-31false13263382GILV SURGICAL LIMITED2025-12-22falseiso4217:GBPxbrli:pure132633822024-03-31132633822025-03-31132633822024-04-012025-03-31132633822023-03-31132633822024-03-31132633822023-04-012024-03-3113263382bus:SmallEntities2024-04-012025-03-3113263382bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113263382bus:FullAccounts2024-04-012025-03-3113263382bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113263382core:WithinOneYear2025-03-3113263382core:AfterOneYear2025-03-3113263382core:WithinOneYear2024-03-3113263382core:AfterOneYear2024-03-3113263382core:ShareCapital2025-03-3113263382core:SharePremium2025-03-3113263382core:RevaluationReserve2025-03-3113263382core:OtherReservesSubtotal2025-03-3113263382core:RetainedEarningsAccumulatedLosses2025-03-3113263382core:ShareCapital2024-03-3113263382core:SharePremium2024-03-3113263382core:RevaluationReserve2024-03-3113263382core:OtherReservesSubtotal2024-03-3113263382core:RetainedEarningsAccumulatedLosses2024-03-3113263382core:LandBuildings2025-03-3113263382core:PlantMachinery2025-03-3113263382core:Vehicles2025-03-3113263382core:FurnitureFittings2025-03-3113263382core:OfficeEquipment2025-03-3113263382core:NetGoodwill2025-03-3113263382core:IntangibleAssetsOtherThanGoodwill2025-03-3113263382core:ListedExchangeTraded2025-03-3113263382core:UnlistedNon-exchangeTraded2025-03-3113263382core:LandBuildings2024-03-3113263382core:PlantMachinery2024-03-3113263382core:Vehicles2024-03-3113263382core:FurnitureFittings2024-03-3113263382core:OfficeEquipment2024-03-3113263382core:NetGoodwill2024-03-3113263382core:IntangibleAssetsOtherThanGoodwill2024-03-3113263382core:ListedExchangeTraded2024-03-3113263382core:UnlistedNon-exchangeTraded2024-03-3113263382core:LandBuildings2024-04-012025-03-3113263382core:PlantMachinery2024-04-012025-03-3113263382core:Vehicles2024-04-012025-03-3113263382core:FurnitureFittings2024-04-012025-03-3113263382core:OfficeEquipment2024-04-012025-03-3113263382core:NetGoodwill2024-04-012025-03-3113263382core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113263382core:ListedExchangeTraded2024-04-012025-03-3113263382core:UnlistedNon-exchangeTraded2024-04-012025-03-3113263382core:MoreThanFiveYears2024-04-012025-03-3113263382core:Non-currentFinancialInstruments2025-03-3113263382core:Non-currentFinancialInstruments2024-03-3113263382dpl:CostSales2024-04-012025-03-3113263382dpl:DistributionCosts2024-04-012025-03-3113263382core:LandBuildings2024-04-012025-03-3113263382core:PlantMachinery2024-04-012025-03-3113263382core:Vehicles2024-04-012025-03-3113263382core:FurnitureFittings2024-04-012025-03-3113263382core:OfficeEquipment2024-04-012025-03-3113263382dpl:AdministrativeExpenses2024-04-012025-03-3113263382core:NetGoodwill2024-04-012025-03-3113263382core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113263382dpl:GroupUndertakings2024-04-012025-03-3113263382dpl:ParticipatingInterests2024-04-012025-03-3113263382dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113263382core:ListedExchangeTraded2024-04-012025-03-3113263382dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113263382core:UnlistedNon-exchangeTraded2024-04-012025-03-3113263382dpl:CostSales2023-04-012024-03-3113263382dpl:DistributionCosts2023-04-012024-03-3113263382core:LandBuildings2023-04-012024-03-3113263382core:PlantMachinery2023-04-012024-03-3113263382core:Vehicles2023-04-012024-03-3113263382core:FurnitureFittings2023-04-012024-03-3113263382core:OfficeEquipment2023-04-012024-03-3113263382dpl:AdministrativeExpenses2023-04-012024-03-3113263382core:NetGoodwill2023-04-012024-03-3113263382core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113263382dpl:GroupUndertakings2023-04-012024-03-3113263382dpl:ParticipatingInterests2023-04-012024-03-3113263382dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113263382core:ListedExchangeTraded2023-04-012024-03-3113263382dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113263382core:UnlistedNon-exchangeTraded2023-04-012024-03-3113263382core:NetGoodwill2025-03-3113263382core:IntangibleAssetsOtherThanGoodwill2025-03-3113263382core:LandBuildings2025-03-3113263382core:PlantMachinery2025-03-3113263382core:Vehicles2025-03-3113263382core:FurnitureFittings2025-03-3113263382core:OfficeEquipment2025-03-3113263382core:AfterOneYear2025-03-3113263382core:WithinOneYear2025-03-3113263382core:ListedExchangeTraded2025-03-3113263382core:UnlistedNon-exchangeTraded2025-03-3113263382core:ShareCapital2025-03-3113263382core:SharePremium2025-03-3113263382core:RevaluationReserve2025-03-3113263382core:OtherReservesSubtotal2025-03-3113263382core:RetainedEarningsAccumulatedLosses2025-03-3113263382core:NetGoodwill2024-03-3113263382core:IntangibleAssetsOtherThanGoodwill2024-03-3113263382core:LandBuildings2024-03-3113263382core:PlantMachinery2024-03-3113263382core:Vehicles2024-03-3113263382core:FurnitureFittings2024-03-3113263382core:OfficeEquipment2024-03-3113263382core:AfterOneYear2024-03-3113263382core:WithinOneYear2024-03-3113263382core:ListedExchangeTraded2024-03-3113263382core:UnlistedNon-exchangeTraded2024-03-3113263382core:ShareCapital2024-03-3113263382core:SharePremium2024-03-3113263382core:RevaluationReserve2024-03-3113263382core:OtherReservesSubtotal2024-03-3113263382core:RetainedEarningsAccumulatedLosses2024-03-3113263382core:NetGoodwill2023-03-3113263382core:IntangibleAssetsOtherThanGoodwill2023-03-3113263382core:LandBuildings2023-03-3113263382core:PlantMachinery2023-03-3113263382core:Vehicles2023-03-3113263382core:FurnitureFittings2023-03-3113263382core:OfficeEquipment2023-03-3113263382core:AfterOneYear2023-03-3113263382core:WithinOneYear2023-03-3113263382core:ListedExchangeTraded2023-03-3113263382core:UnlistedNon-exchangeTraded2023-03-3113263382core:ShareCapital2023-03-3113263382core:SharePremium2023-03-3113263382core:RevaluationReserve2023-03-3113263382core:OtherReservesSubtotal2023-03-3113263382core:RetainedEarningsAccumulatedLosses2023-03-3113263382core:AfterOneYear2024-04-012025-03-3113263382core:WithinOneYear2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113263382core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113263382core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113263382core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113263382core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113263382core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113263382bus:Director12024-04-012025-03-31

GILV SURGICAL LIMITED

Registered Number
13263382
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

GILV SURGICAL LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

GILVETTI, Ciro

Registered Address

Flat 3 36 Lincoln Road
London
SE25 4HQ

Registered Number

13263382 (England and Wales)
GILV SURGICAL LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets37,2095,264
7,2095,264
Current assets
Debtors424,85615,489
Cash at bank and on hand7,36535,899
32,22151,388
Creditors amounts falling due within one year5(9,334)(19,709)
Net current assets (liabilities)22,88731,679
Total assets less current liabilities30,09636,943
Provisions for liabilities6(1,802)(1,316)
Net assets28,29435,627
Capital and reserves
Called up share capital100100
Profit and loss account28,19435,527
Shareholders' funds28,29435,627
The financial statements were approved and authorised for issue by the Director on 22 December 2025, and are signed on its behalf by:
GILVETTI, Ciro
Director
Registered Company No. 13263382
GILV SURGICAL LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
2.Average number of employees

20252024
Average number of employees during the year00
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 243,6814,4328,113
Additions3,394-3,394
At 31 March 257,0754,43211,507
Depreciation and impairment
At 01 April 241,3641,4852,849
Charge for year7127371,449
At 31 March 252,0762,2224,298
Net book value
At 31 March 254,9992,2107,209
At 31 March 242,3172,9475,264
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables8,06914,868
Other debtors16,265100
Prepayments and accrued income522521
Total24,85615,489
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security9,24418,124
Other creditors-1,585
Accrued liabilities and deferred income90-
Total9,33419,709
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)1,8021,316
Total1,8021,316
7.Directors advances, credits and guarantees
The director`s current account has a debit balance of £16,165 (2024: £1,585 cr) relates to the director, C Gilvetti.